ageas Balans Gezondheid

Financiële gezondheid criteriumcontroles 3/6

ageas heeft een totaal eigen vermogen van €8.5B en een totale schuld van €6.1B, wat de schuld-eigenvermogensverhouding op 71.5% brengt. De totale activa en totale passiva bedragen respectievelijk €96.8B en €88.2B. De EBIT ageas is €971.0M waardoor de rentedekking 3.9 is. Het heeft contanten en kortetermijnbeleggingen van €23.7B.

Belangrijke informatie

71.5%

Verhouding schuld/eigen vermogen

€6.11b

Schuld

Rente dekkingsratio	3.9x
Contant	€23.68b
Aandelen	€8.54b
Totaal verplichtingen	€88.25b
Totaal activa	€96.79b

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Industry Analysts Just Upgraded Their ageas SA/NV (EBR:AGS) Revenue Forecasts By 78%

Sep 29

Analysts' Revenue Estimates For ageas SA/NV (EBR:AGS) Are Surging Higher

Aug 15

Little Excitement Around ageas SA/NV's (EBR:AGS) Earnings

Jul 29

We think ageas SA/NV's (EBR:AGS) CEO May Struggle To See Much Of A Pay Rise This Year

May 09

ageas (EBR:AGS) Has Compensated Shareholders With A Respectable 62% Return On Their Investment

Feb 02

With EPS Growth And More, ageas (EBR:AGS) Is Interesting

Dec 31

Is It Worth Buying ageas SA/NV (EBR:AGS) For Its 6.3% Dividend Yield?

Dec 05

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( €26.8B ) AGS } overtreffen de korte termijn passiva ( €5.2B ).

Langlopende schulden: De kortetermijnactiva van AGS ( €26.8B ) dekken de langetermijnschulden ( €83.1B ) niet.

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: AGS heeft meer geld in kas dan de totale schuld.

Schuld verminderen: De schuld/eigen vermogen-ratio van AGS is de afgelopen 5 jaar gestegen van 35.9% naar 71.5%.

Schuldendekking: De schuld van AGS wordt niet goed gedekt door de operationele kasstroom ( 12% ).

Rentedekking: De rentebetalingen op de schuld van AGS worden goed gedekt door EBIT ( 3.9 x dekking).

ageas Balans Gezondheid

Financiële gezondheid criteriumcontroles 3/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Recent updates

Industry Analysts Just Upgraded Their ageas SA/NV (EBR:AGS) Revenue Forecasts By 78%

Consensus revenue estimates increase by 78%

Consensus revenue estimates decrease by 44%, EPS upgraded

First half 2024 earnings released: EPS: €3.49 (vs €2.89 in 1H 2023)

ageas SA/NV (ENXTBR:AGS) announces an Equity Buyback for €200 million worth of its shares.

New major risk - Financial position

ageas SA/NV Declares Interim Gross Cash Dividend for the Fiscal Year 2024

Analysts' Revenue Estimates For ageas SA/NV (EBR:AGS) Are Surging Higher

Consensus revenue estimates increase by 53%

Little Excitement Around ageas SA/NV's (EBR:AGS) Earnings

ageas SA/NV to Report First Half, 2024 Results on Aug 28, 2024

Upcoming dividend of €1.23 per share

We think ageas SA/NV's (EBR:AGS) CEO May Struggle To See Much Of A Pay Rise This Year

Final dividend of €1.23 announced

Insufficient Growth At ageas SA/NV (EBR:AGS) Hampers Share Price

Ageas Plans Not to Make Further Offer for Direct Line Insurance

BNP Paribas Reportedly Considers Buying Fosun's Ageas Stake

What You Need To Know About The ageas SA/NV (EBR:AGS) Analyst Downgrade Today

Consensus revenue estimates decrease by 12%

Direct Line Soars as Ageas Mulls 3.10b Bid

ageas SA/NV to Report Fiscal Year 2023 Final Results on Apr 12, 2024

Upcoming dividend of €1.05 per share at 7.7% yield

New major risk - Revenue and earnings growth

La Mutuelle Epargne Retraite Prévoyance Carac acquired French Life Insurance activities of Ageas.

ageas (EBR:AGS) Has Affirmed Its Dividend Of €1.05

Consensus revenue estimates decrease by 15%, EPS upgraded

First half 2023 earnings released: EPS: €2.89 (vs €3.05 in 1H 2022)

New major risk - Revenue and earnings growth

Upcoming dividend of €1.05 per share at 7.4% yield

ageas SA/NV to Report First Half, 2023 Results on Aug 30, 2023

Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

ageas SA/NV to Report Fiscal Year 2022 Final Results on Mar 31, 2023

ageas SA/NV, Annual General Meeting, May 17, 2023

Ageas Announces CFO Changes

Upcoming dividend of €1.05 per share

ageas SA/NV Announces Interim Dividend for the Year 2022

Upcoming dividend of €1.93 per share

First quarter 2022 earnings: Revenues miss analyst expectations

ageas (EBR:AGS) Is Increasing Its Dividend To €1.93

ageas (EBR:AGS) Is Increasing Its Dividend To €1.93

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

ageas' (EBR:AGS) Upcoming Dividend Will Be Larger Than Last Year's

Consensus forecasts updated

Ageas Sa/Nv Proposes Gross Cash Dividend

Second quarter 2021 earnings released: EPS €0.60 (vs €1.78 in 2Q 2020)

ageas SA/NV (ENXTBR:AGS) announces an Equity Buyback for €150 million worth of its shares.

Ageas May Up Stake in Federal Life to 74%’

Full year 2020 earnings released: EPS €6.07 (vs €5.09 in FY 2019)

Is It Worth Buying ageas SA/NV (EBR:AGS) For Its 5.3% Dividend Yield?

New 90-day high: €47.23

ageas SA/NV to Report Q1, 2021 Results on May 12, 2021

ageas (EBR:AGS) Has Compensated Shareholders With A Respectable 62% Return On Their Investment

ageas SA/NV to Report First Half, 2021 Results on Aug 11, 2021

New 90-day high: €44.34

With EPS Growth And More, ageas (EBR:AGS) Is Interesting

New 90-day high: €43.36

Is It Worth Buying ageas SA/NV (EBR:AGS) For Its 6.3% Dividend Yield?

Ageas Announces Management Changes, Effective November 1, 2020

BE Group AB (publ) (OM:BEGR) cancelled the acquisition of ageas SA/NV (ENXTBR:AGS).

ageas SA/NV Announces Executive Changes, Effective October 22, 2020

New 90-day high - €36.75

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Ontdek gezonde bedrijven